Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Yikes excitement around the Q ...

<< Previous

Bullboard Posts

Next >>

Comment by Lee430on Apr 13, 2021 5:25pm

162 Views

Post# 32989627

RE:RE:Yikes excitement around the Q ...

So is tomorrow going to be groundhog day again or the start of our bull run to at least fair market value compared to out peers? I am going to hold off on that down payment to a mega yacht for now ;->

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver